Which medication category does prednisone belong to when treating asthma?

Which medication category does prednisone belong to when treating asthma?

• A. Short-acting beta2 agonist
• B. Cholinergic antagonist
• C. Corticosteroid
• D. Leukotriene modifier

Answer: (C)

Prednisone is classified as a corticosteroid, which is a type of medication commonly used in the management of asthma. Corticosteroids, like prednisone, work by reducing inflammation in the airways, decreasing mucus production, and improving overall airway function. This anti-inflammatory effect is crucial, especially during asthma exacerbations, as it helps to alleviate symptoms such as wheezing, coughing, and shortness of breath. Corticosteroids can be used for both acute treatment, such as in severe asthma attacks, and as a long-term management strategy to prevent future exacerbations. By managing airway inflammation, they contribute to improved breathing and overall control of asthma symptoms. Other medication categories, such as short-acting beta2 agonists, cholinergic antagonists, and leukotriene modifiers, have different mechanisms of action and specific roles in asthma treatment, but none serve the same anti-inflammatory purpose as corticosteroids. Short-acting beta2 agonists act as bronchodilators to quickly relieve asthma symptoms, cholinergic antagonists help reduce mucus production but do not directly address inflammation, and leukotriene modifiers work by blocking substances in the immune system that contribute to asthma, without the broader anti-inflammatory effects that corticosteroids provide.

Prednisone is classified as a corticosteroid, which is a type of medication commonly used in the management of asthma. Corticosteroids, like prednisone, work by reducing inflammation in the airways, decreasing mucus production, and improving overall airway function. This anti-inflammatory effect is crucial, especially during asthma exacerbations, as it helps to alleviate symptoms such as wheezing, coughing, and shortness of breath.

Corticosteroids can be used for both acute treatment, such as in severe asthma attacks, and as a long-term management strategy to prevent future exacerbations. By managing airway inflammation, they contribute to improved breathing and overall control of asthma symptoms.

Other medication categories, such as short-acting beta2 agonists, cholinergic antagonists, and leukotriene modifiers, have different mechanisms of action and specific roles in asthma treatment, but none serve the same anti-inflammatory purpose as corticosteroids. Short-acting beta2 agonists act as bronchodilators to quickly relieve asthma symptoms, cholinergic antagonists help reduce mucus production but do not directly address inflammation, and leukotriene modifiers work by blocking substances in the immune system that contribute to asthma, without the broader anti-inflammatory effects that corticosteroids provide.